COPD is the third most common cause of death globally. Adherence rates in patients with obstructive pulmonary diseases usually range between 10% and 40%. The aim of the study was to evaluate the level of treatment adherence to inhaled therapy in patients with obstructive pulmonary diseases. A total of 325 patients, of mean age 63.04 ± 11.29, with COPD or asthma, were included into the study between 2020 and 2021. The following questionnaires were used: Beliefs about Medicines Questionnaire, Test of Adherence to Inhalers and Adherence to Refills and Medications Scale. The respondents tended to be convinced of the necessity of their medication (3.87 points per question). The patients reported moderate levels of overall adherence (21.15 ± 6.23). A total of 74% of patients demonstrated sporadic non-compliance. We conclude that patients with obstructive pulmonary diseases are moderately adherent to their medication. Beliefs about medicines have a significant impact on adherence to medications. Being unemployed, being a non-smoker and belief in the necessity of medication are independent determinants of better medication adherence. The number of hospital admissions due to exacerbations of the disease over the last year and belief that medicines are harmful are independent determinants of poorer medication adherence.
Jakość życia pacjentek z rozpoznaniem nowotworu piersiQuality of life in patients diagnosed with breast cancer Streszczenie Rak piersi stanowi drugą co do częstości przyczynę zgonów spowodowanych przez nowotwory złośliwe u kobiet. Rak piersi we wczesnych stadiach rozwoju nie wywołuje objawów, jednak w okresie zaawansowanej choroby powoduje liczne objawy fizyczne, ale także zaburza funkcjonowanie w sferze psychologicznej, społecznej, rodzinnej, seksualnej i duchowej. Jakość życia związana ze stanem zdrowia stanowi najważniejszy aspekt życia każdego człowieka. Kobiety z rozpoznaniem raka piersi cechuje obniżona jakość życia, w porównaniu z populacją zdrową. Ocena jakości życia kobiet z rakiem piersi, jako chorobą dającą odległe skutki, jest niezwykle istotna, również dla powodzenia leczenia przeciwnowotworowego i objawowego. Wśród czynników warunkujących jakość życia wymieniane są 4 grupy: zmienne socjodemograficzne, zmienne kliniczne, czynniki psychosocjalne i przekonania zdrowotne. Ocena jakości życia pozwala dobrać korzystne dla pacjentki leczenie, a poziom jakości życia posiada także znaczenie rokownicze. Interwencje mające na celu poprawę jakości życia mogą wydłużyć czas przeżycia kobiet z rakiem piersi. AbstractBreast cancer is the second most common cause of death caused by malignant tumors in women. Initially, breast cancer does not give symptoms, but then it manifests itself not only with unpleasant physical and mental symptoms, but also disturbs functioning in the social, family or sexual sphere. The quality of life associated with the state of health is the most important aspect of every human life. Unfortunately, women with breast cancer still have a reduced quality of life in relation to the healthy population. Assessing the quality of life of women with breast cancer as a disease with long-term effects is extremely important also for the success of the therapy. Among the determinants of quality of life 4 groups are mentioned: sociodemographic variables, clinical variables, psychosocial factors and health convictions. The assessment of quality of life allows us to choose a treatment beneficial for the patient and also has prognostic importance. Interventions to improve the quality of life can increase the survival of women with breast cancer. Palliat Med Pract 2018; 12, 3: 143-150
Introduction. Asthma and COPD are extremely common respiratory diseases that have a serious impact on people’s lives around the world. A disease characterized by symptoms characteristic for asthma and COPD is called asthma-COPD overlap (ACO). Fatigue and certain psychological disorders such as anxiety and depression are important comorbidities in these diseases. The purpose of this study was to assess the prevalence of fatigue, anxiety, and depression in patients with asthma, COPD, and ACO and to also consider their mutual correlations. Material and Methods. A total of 325 patients were enrolled in the study. There were 159 women and 166 men and their mean age was 63. Two standardized questionnaires were used: the Modified Fatigue Impact Scale (MFIS) and the Hospital Anxiety and Depression Scale (HADS). Results. The mean total MFIS score for all patients was 33.03. Patients with asthma generally scored lower than patients with COPD and ACO. There were no statistical differences in the HADS for anxiety between the groups, although around half of the patients registered a score indicating some level of disorder. Patients with COPD and ACO were proven to suffer more from depression than patients with asthma. The HADS and MFIS scores were found to correlate significantly and positively. Conclusions. Our study showed that patients with COPD, asthma, and ACO generally suffered from an increased level of fatigue and depression. Anxiety was high in all groups, but it was at a similar level for patients suffering from each of the three diseases under consideration. It is important to treat the physical symptoms as well as the psychological disorders since they greatly impact on the patient outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.